Oncology conference series 2017 schedule release

Meet inspiring speakers and experts at 3000+ global series annual meetings

With its 3000+ global events, including 1000+ scientific conferences, 2000+ International workshops, seminars, exhibitions and symposia, Conference series is all set to offer a  global platform for discussion and knowledge sharing on growing cancer menace across america, Europe, the Middle East, and Asia Pacific during 2016- 2017.

Cancer is no longer a rare disease confined to the high income generating nations alone. It is the second leading cause of death worldwide and the growing number of cancer incidences across the countries of the globe is a major health concern today. In 2013 around 14.1 million new cases and approximately 8.2 million cancer deaths has been reported. This number is anticipated to rise up to 20% by 2010-2030, primarily due to ageing and increased exposure to the risk factors, leading to cancer. Breast cancer, blood cancer, Liver cancer, and Stomach cancer are accounting to nearly half of the global cancer deaths.  

The global treatment market for  cancers like which  breast, colorectal, lung and prostate cancers, among others, will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, at a compound annual growth rate (CAGR) of 9.9%, according to business intelligence provider GBI Research. The global cancer diagnostics market was valued at USD 101.0 billion in 2013 and is expected to grow at a CAGR of 7.6% from 2014 to 2020, to reach an estimated value of USD 168.6 billion in 2020. USA, France, Germany, Italy, Spain, United Kingdom and Japan were the seven affected regions, representing 79% of the affected population ($43 billion) in 2010.

The social impact of cancer on US society is immense. By 2017, approximately 2,245,110 new cases of cancer will be diagnosed in US alone with a high mortality rate, as 595,690 may die due to it. The number of people living with cancer reached nearly 14.5 million in 2014 and is predicted to reach 19 million by 2024. The US cancer care industry was $125 billion in 2010 and it is expected to reach $156 billion in 2020.

In Middle-East, cancer diagnostics and therapeutics market as of now is estimated to be $467.04 million in 2015 and is anticipated to achieve USD 4 Billion by 2020 with a development rate of 13%. For instance, almost 50% of breast cancer patients in the Middle East are diagnosed at a median age of 49-52, compared to a median age of 63 in Western countries.

Taking the current scenarios into consideration, there is need for disseminate the knowledge & discussions are required to fight against the dreadful disease. Adding to the list of Cancer conferences,   Conference series LLC is organizing the 18th Euro Cancer Science and Therapy Congress which is going to be held In Lisbon, Portugal during July 20-22, 2017. This unique international conference provides a platform for researchers and decision makers in cancer research to present their latest findings and learn about all the important developments in cancer research. Throughout the course of the three day conference, the opportunity to both network and hear leaders from the international academic and corporate cancer research communities can be availed.

According to the World Health Organization, Asia's prevalence of cancer deaths may climb from 45% to 163 % which approximately 100,000 people by 2030. Rate of cancer casesin Asia may jump by almost 60% to 7.1 million new cases a year by 2020.The incidence of cancer cases is estimated to increase from 6.1 million in 2008 to 10.6 million in 2030, due to ageing and growing populations, lifestyle and socioeconomic changes.

To provide global platforms for discussion and knowledge exchange among the well renowned researchers and scientists, Conference Series is organizing oncology meetings every year on wide range of cancer topics. All the important and informative cancer research topics are discussed in these conferences. Scientific sessions of these international conferences includes discussion about the diseases such as Breast Cancer, Blood Cancer, Pancreatic Cancer, Oral Cancer, Prostate Cancer, Liver Cancer, its prevention and other  diagnosis as well as treatment based sessions which are Biomarkers, Cancer Drugs, Radiology, Anti-Cancer Therapy, surgery and Transplantations.

Conference Series and it’s partner open access journals publishers owns and operates 700 peer reviewed journals is visited by 30 million online visitors, supported by 1000+ scientific and business collaborations. Majority of the International Conferences organized by Conference series are providing CME, CE and CPD credits. At these CME Oncology conferences and CME Radiology meetings distinguished speakers from different parts of the world would be delivering vital and though provoking talk on all key topics, unveiling the recent innovations in cancer research.